| New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) EA Eisenhauer, P Therasse, J Bogaerts, LH Schwartz, D Sargent, R Ford, ... European journal of cancer 45 (2), 228-247, 2009 | 27974 | 2009 |
| Remdesivir for the treatment of Covid-19 JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ... New England Journal of Medicine 383 (19), 1813-1826, 2020 | 8198 | 2020 |
| The lung image database consortium (LIDC) and image database resource initiative (IDRI): a completed reference database of lung nodules on CT scans SG Armato III, G McLennan, L Bidaut, MF McNitt‐Gray, CR Meyer, ... Medical physics 38 (2), 915-931, 2011 | 2413 | 2011 |
| Baricitinib plus remdesivir for hospitalized adults with Covid-19 AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ... New England Journal of Medicine 384 (9), 795-807, 2021 | 1758 | 2021 |
| A randomized, controlled trial of Ebola virus disease therapeutics S Mulangu, LE Dodd, RT Davey Jr, O Tshiani Mbaya, M Proschan, ... New England journal of medicine 381 (24), 2293-2303, 2019 | 1654 | 2019 |
| A randomized, controlled trial of ZMapp for Ebola virus infection Prevail II Writing Group New England Journal of Medicine 375 (15), 1448-1456, 2016 | 480 | 2016 |
| Partial AUC estimation and regression LE Dodd, MS Pepe Biometrics 59 (3), 614-623, 2003 | 440 | 2003 |
| Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure ST Malherbe, S Shenai, K Ronacher, AG Loxton, G Dolganov, M Kriel, ... Nature medicine 22 (10), 1094-1100, 2016 | 276 | 2016 |
| A cautionary note on the robustness of latent class models for estimating diagnostic error without a gold standard PS Albert, LE Dodd Biometrics 60 (2), 427-435, 2004 | 236 | 2004 |
| Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome S Marais, G Meintjes, DJ Pepper, LE Dodd, C Schutz, Z Ismail, ... Clinical infectious diseases 56 (3), 450-460, 2013 | 216 | 2013 |
| Blinded independent central review of progression-free survival in phase III clinical trials: important design element or unnecessary expense? LE Dodd, EL Korn, B Freidlin, CC Jaffe, LV Rubinstein, J Dancey, ... Journal of Clinical Oncology 26 (22), 3791, 2008 | 191 | 2008 |
| Profiling human serum antibodies with a carbohydrate antigen microarray O Oyelaran, LM McShane, L Dodd, JC Gildersleeve Journal of proteome research 8 (9), 4301-4310, 2009 | 181 | 2009 |
| Remdesivir for the treatment of Covid-19-preliminary report. Reply. JH Beigel, KM Tomashek, LE Dodd The New England journal of medicine 383 (10), 994-994, 2020 | 159 | 2020 |
| PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis RY Chen, LE Dodd, M Lee, P Paripati, DA Hammoud, JM Mountz, D Jeon, ... Science translational medicine 6 (265), 265ra166-265ra166, 2014 | 155 | 2014 |
| Validation of novel imaging methodologies for use as cancer clinical trial end-points DJ Sargent, L Rubinstein, L Schwartz, JE Dancey, C Gatsonis, LE Dodd, ... European journal of cancer 45 (2), 290-299, 2009 | 145 | 2009 |
| Evaluation of tuberculosis diagnostics in children: 2. Methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic … LE Cuevas, R Browning, P Bossuyt, M Casenghi, MF Cotton, AT Cruz, ... Journal of Infectious Diseases 205 (suppl_2), S209-S215, 2012 | 142 | 2012 |
| Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial AC Kalil, AK Mehta, TF Patterson, N Erdmann, CA Gomez, MK Jain, ... The lancet respiratory medicine 9 (12), 1365-1376, 2021 | 141 | 2021 |
| PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis MT Coleman, RY Chen, M Lee, PL Lin, LE Dodd, P Maiello, LE Via, Y Kim, ... Science translational medicine 6 (265), 265ra167-265ra167, 2014 | 138 | 2014 |
| Lessons learned from independent central review R Ford, L Schwartz, J Dancey, LE Dodd, EA Eisenhauer, S Gwyther, ... European journal of cancer 45 (2), 268-274, 2009 | 130 | 2009 |
| Recommendations for the assessment of progression in randomised cancer treatment trials JE Dancey, LE Dodd, R Ford, R Kaplan, M Mooney, L Rubinstein, ... European journal of cancer 45 (2), 281-289, 2009 | 130 | 2009 |
